Oncology
2237 articles · 70 journals
Publication dynamics
Journals in this subcategory (70)
- Blood Neoplasia · Elsevier (90)
- Biochimica et Biophysica Acta: Reviews on Cancer · Elsevier (89)
- European Journal of Surgical Oncology · Elsevier (85)
- Cancer Treatment and Research Communications · Elsevier (83)
- The Lancet Oncology · Elsevier (83)
- Brachytherapy · Elsevier (81)
- Cancer Epidemiology · Elsevier (80)
- Journal of Thoracic Oncology · Elsevier (80)
- International Journal of Gynecological Cancer · Elsevier (79)
- EJC Skin Cancer · Elsevier (76)
- Asia-Pacific Journal of Clinical Oncology · Wiley (72)
- Lung Cancer · Elsevier (68)
- Critical Reviews in Oncology/Hematology · Elsevier (66)
- Surgical Oncology Clinics of North America · Elsevier (66)
- European Journal of Cancer · Elsevier (65)
- Leukemia Research Reports · Elsevier (65)
- Gynecologic Oncology Reports · Elsevier (62)
- Bulletin du Cancer · Elsevier (59)
- Translational Oncology · Elsevier (58)
- Urologic Oncology: Seminars and Original Investigations · Elsevier (58)
- Blood Reviews · Elsevier (54)
- Journal of the National Cancer Center · Elsevier (53)
- The Journal of Liquid Biopsy · Elsevier (52)
- Leukemia Research · Elsevier (51)
- Cancer Letters · Elsevier (50)
- Trends in Cancer · Elsevier (49)
- JACC: CardioOncology · Elsevier (46)
- Surgical Oncology Insight · Elsevier (43)
- Clinical Breast Cancer · Elsevier (39)
- ESMO Open · Elsevier (38)
- Cancer Pathogenesis and Therapy · Elsevier (37)
- Clinical Lung Cancer · Elsevier (32)
- Journal of Geriatric Oncology · Elsevier (30)
- Current Problems in Cancer: Case Reports · Elsevier (29)
- Journal of Bone Oncology · Elsevier (27)
- Precision Radiation Oncology · Wiley (20)
- Intelligent Oncology · Elsevier (18)
- Current Problems in Cancer · Elsevier (17)
- Immuno-Oncology and Technology · Elsevier (16)
- npj Precision Oncology · Springer Nature (12)
- Best Practice & Research Clinical Haematology · Elsevier (11)
- MedComm - Oncology · Wiley (10)
- European Journal of Cancer: Supplement · Elsevier (9)
- Nature Reviews Cancer · Springer Nature (9)
- Nature Reviews Clinical Oncology · Springer Nature (8)
- British Journal of Cancer · Springer Nature (7)
- Cancer Cytopathology · Wiley (5)
- BMC Cancer · Springer Nature (0)
- Breast Cancer Research · Springer Nature (0)
- Breast Cancer Research and Treatment · Springer Nature (0)
- Cancer Cell International · Springer Nature (0)
- Cancer Chemotherapy and Pharmacology · Springer Nature (0)
- Cancer and Metastasis Reviews · Springer Nature (0)
- Cardio-Oncology · Springer Nature (0)
- Cellular Oncology · Springer Nature (0)
- Clinical and Translational Oncology · Springer Nature (0)
- Current Breast Cancer Reports · Springer Nature (0)
- Current Hematologic Malignancy Reports · Springer Nature (0)
- Current Oncology Reports · Springer Nature (0)
- Immuno-Oncology · Springer Nature (0)
- Indian Journal of Gynecologic Oncology · Springer Nature (0)
- Indian Journal of Surgical Oncology · Springer Nature (0)
- Journal of Cancer Research and Clinical Oncology · Springer Nature (0)
- Journal of Gastrointestinal Cancer · Springer Nature (0)
- Journal of Mammary Gland Biology and Neoplasia · Springer Nature (0)
- Journal of the Egyptian National Cancer Institute · Springer Nature (0)
- Molecular Cancer · Springer Nature (0)
- Oncology and Therapy · Springer Nature (0)
- Strahlentherapie und Onkologie · Springer Nature (0)
- best practice onkologie · Springer Nature (0)
- P0304: Technical Development and Procedural Validation of Gelatin-Agar and Silicone-Based Phantoms for Ultrasound-Guided Interstitial Brachytherapy Simulation
- The gut microbiome in B cell lymphoma
- P0305: Doppler Guided Interstitial Brachytherapy for Residual Neck Node Metastases
- CAR-T for all? Barriers, facilitators, and interventions to commercial CAR T-cell therapy access
- P0306: Ureteroscopic-Guided Fractionated Endoluminal HDR Brachytherapy for High-Grade Ureteral Carcinoma in a Medically Inoperable Patient
- Resistance to CD20×CD3 Bispecific Antibodies in B-Cell Lymphoma: Mechanisms and Emerging Therapeutic Strategies
- Unmasking BCL2A1: IL10/STAT3-Driven BCL2A1 Expression Promotes Apoptosis Resistance in DLBCL
- Racial and socioeconomic disparities in clinical trial participation and outcomes in systemic peripheral T-cell lymphoma
- Impact of testing for genetic markers on treatment selection and clinical outcomes among patients with chronic lymphocytic leukemia
- Targeted Therapy Yields Early Neurologic Improvement in Central Nervous System Histiocytic Neoplasms
- An updated systematic review and meta-analysis of Caplacizumab for immune thrombotic thrombocytopenic purpura: Insights into efficacy and safety
- Metabolic alterations in multiple myeloma and extramedullary disease- a novel niche of therapeutic targets
- SNARE proteins: Core engines of membrane fusion in cancer
- CARM1 in human cancer: a multifunctional epigenetic node driving tumor plasticity and therapeutic vulnerability
- B-MYB (MYBL2): from cell cycle regulator to an oncogenic player
- Immunopeptidomics in gliomas: Decoding antigen presentation for precision immunotherapy
- Long non-coding RNAs as master regulators of cancer metastasis and therapeutic resistance
- RBM15 in leukemogenesis: an emerging regulator at the interface of RNA biology and hematopoiesis
- Exploiting DNA damage tolerance for precision oncology
- Cancer-associated synonymous mutations target mRNA structures and protein activity
- Heterotypic tumor microenvironments mirror dynamic wound-healing process
- Fusion-product control in hematologic cancers
- Next-generation tumor-agnostic targets on the horizon
- Macrophage-directed therapeutic strategies in cancer
- Circulating tumor cell–immune cell clusters: dynamic engines of metastasis
- Integrating biology and mathematics to understand checkpoint immunotherapy
- A new phase in KRAS signaling
- Drugging the undruggable: early phase trial shows trabectedin and low-dose irinotecan downregulate EWSR1::FLI1 and has clinical activity in advanced Ewing sarcoma
- Host metabolism rewrites metastatic fate
- Accelerating rare cancer research: a Zebrafish-First Triage Strategy